[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

10x Genomics, Inc. Class A Common Stock (TXG)

10x Genomics stock sees high engagement with bullish sentiment despite a target price cut; high social interest and Cathie Wood's investment suggest a potential rebound.

About 10x Genomics, Inc. Class A Common Stock

10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded stock for a company focused on genomic research.
10x Genomics, Inc. Class A Common Stock uses the ticker $TXG for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

10x Genomics, Inc. Class A Common Stock (TXG) trading volume is up XXXXX% from the previous week.
10x Genomics, Inc. Class A Common Stock (TXG) creators is up XXX% from the previous month.
10x Genomics, Inc. Class A Common Stock (TXG) engagements is up XXXXX% from the previous week.
10x Genomics, Inc. Class A Common Stock (TXG) mentions is up XXXXXX% from the previous month.
10x Genomics, Inc. Class A Common Stock (TXG) posts created is up XXXXXX% from the previous month.

Price: $XXXXX #

Price 24-Hour Chart Data
The price decrease is likely due to Morgan Stanley's target price cut, but high social engagement and Cathie Wood's investment suggest a potential rebound, indicating a period of volatility with potential for growth.

24-Hour	7-Day	30-Day
-XXX%	XXXXX%	XXXXX%

1-Year High: $XXXXX on 2024-08-23
1-Year Low: $XXXX on 2025-04-08

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
10x Genomics, Inc. Class A Common Stock (TXG) is currently AltRank #1,017 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX -XXXXX
6 Months: XXX -XXX
1 Year: XXX -XX
1-Year High: XXXXX on 2025-05-25
1-Year Low: XX on 2025-01-25

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -X
6 Months: XX -X
1 Year: XX +26
1-Year High: XX on 2025-04-14
1-Year Low: XX on 2024-12-18

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +25%
1 Month: XXXXXXX +12%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX +7.20%
1-Year High: XXXXXXX on 2025-02-12
1-Year Low: XX on 2025-07-24

Social Network	X
Engagements	XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +28%
1 Month: XXX +319%
6 Months: XXXXX -XX%
1 Year: XXXXX +41%
1-Year High: XXX on 2024-10-11
1-Year Low: X on 2025-07-24

Social Network	X
Mentions	XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning 10x Genomics, Inc. Class A Common Stock (TXG) in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX +14%
1 Month: XXX +505%
6 Months: XXX +5.40%
1 Year: XXXXX +191%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-07-24

The most influential creators that mention 10x Genomics, Inc. Class A Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@FriarTuck198979	X	XXXXX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% +10%
1 Year: XXX% +75%
1-Year High: XXX% on 2024-08-25
1-Year Low: XX% on 2024-08-31

Most Supportive Themes

Biotech Stock Potential & Analyst Target Price: (80%) Positive sentiment surrounds the potential of the biotech stock and an optimistic analyst target price despite the reduction. High social engagement and recent investments may indicate confidence in TXG's future.

Most Critical Themes

Morgan Stanley Target Reduction: (15%) Investors are reacting negatively to Morgan Stanley's target price reduction for TXG.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXXXX	XX%	XX	X%

Total	XXX	XX%	XXXXX	XX%	XX	X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% -XXXXXXX%
1 Month: XXXXXXX% -XXXXXXX%
6 Months: XXXXXXX% -XXXXX%
1 Year: XXXXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-10-10
1-Year Low: XXXXXXX% on 2025-07-24

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXX% on 2024-09-02
1-Year Low: XXXXXXX% on 2025-07-23

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$9%
1 Month: $XXXXXXXXXXXXX +$26%
6 Months: $XXXXXXXXXXXXX -$6.50%
1 Year: $XXXXXXXXXXXXX -$26%
1-Year High: $XXXXXXXXXXXXX on 2024-08-23
1-Year Low: $XXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about 10x Genomics, Inc. Class A Common Stock in the last XX hours

Dave Inc. Class A Common Stock (DAVE) TeraWulf Inc. (WULF) Hims & Hers Health, Inc. (HIMS) Hims & Hers Health, Inc. (HIMS) CYCLEAN (CCL) Advanced Micro Devices (AMD) Tesla, Inc. (TSLA) ATAI Life Sciences (ATAI) Invesco Ltd. (IVZ)

Top topics mentioned In the posts about 10x Genomics, Inc. Class A Common Stock in the last XX hours

meta, amc, gme, amzn, spy, telo, mira, pltr, mining, leo, bbb, hong kong dollar, mrna, $jmia, $comm, dtc, qqq, spx, manat, stocks, xpof, hims, $tigr, nvda, qubt, fwrd, $dave, $wulf, $srfm, rio, dg, agi, $cvv, hood, sonn, investment, $hims, hims hers, stocks consumer defensive, cmg, $nvdl, $vxx, fund manager, $xlk, acquisition, $rslvv, $rslv, $txgto, arx, mauritanian ouguiya, pow, $ineto, $ine, $md, $lgo, market cap, apld, $ccl, $amd, $tsla, $atai, $ivz, $rkt, $urgn, $gpat, xyz, ter, vsat, $negg, icu, $fpi, $pnst, $trup, $om, $car, $aehr, $wbd, clsk, $btbt, $pd, nmr, $jl, $netdu, singapore dollar, ego, nem, wat, $suns, $jspr, $ghrs, copper, $wpgcf, $wpg, $omi, $leg, $tti, vivo, $121m, $qntm, $cyl